The global ophthalmic ultrasound devices market size was estimated to be USD 0.494 billion in 2023 and is expected to reach at USD 1.20 billion by 2034 with a CAGR of 8.37% during the forecast period 2024-2034. The increasing occurrence of ophthalmic conditions like diabetic retinopathy and cataracts, a rise in the introduction of new products, efficient reimbursement policies, a surge in cataract surgeries, a growing prevalence of lifestyle- and age-related eye conditions, an elevated number of diabetic retinopathy cases, and an increase in regulatory approvals for innovative ophthalmic ultrasound devices are some of the key factors boosting the market growth.
The Ophthalmic Ultrasound Device plays a vital role in swiftly and non-invasively assessing the eye and orbit. This device becomes essential when manual examination of the eye is challenging. A-scan and B-scan are the two most frequently employed types of Ophthalmic ultrasound devices, used in conjunction to identify eye abnormalities. Ultrasound devices find application in detecting conditions such as choroidal melanoma, retinal detachment, and visualizing lens dislocation. An increase in regulatory approvals for innovative ophthalmic ultrasound devices is predicted to boost the market growth during the forecast period. For instance, in January 2023, The Sunkingdom Ophthalmic Ultrasound Examination Instrument, comprising models SK-3000A, SK-3000B, SK-3000C, SK-2000AP, SK-2000A, and SK-2000P, has received approval from the FDA. Developed by Chongqing Sunkingdom Medical Instrument Co., Ltd., this ultrasound imaging system is designed for ophthalmic applications.
By product, A-scan product was the highest revenue-grossing segment in the global ophthalmic ultrasound devices market in 2023 owing to the extensive utilization of A-scan devices for the pre-operative assessment of conditions like vitreous hemorrhage, peri-orbital trauma, or lens opacification in cases involving a detached retina, offering advantages in cataract surgeries. A-scan employs state-of-the-art transducer and electronic technologies to ensure remarkable reliability and precision in ophthalmology procedures. Additionally, B-scan is predicted to grow at the fastest CAGR during the forecast period owing to the expanding accessibility of these compact, cost-effective, lightweight, and versatile devices, an escalating incidence of diverse diseases, a rising prevalence of diabetic retinopathy, a surge in initiatives by market participants, and an increasing introduction of cutting-edge systems. For instance, in January 2024, FUJIFILM Sonosite Inc. has unveiled the Sonosite LX system in multiple European countries. This latest ultrasound system showcases the company's most extensive clinical image and includes a monitor that can extend, rotate, and tilt, facilitating improved real-time collaboration among healthcare providers.
By modality, standalone devices was the highest revenue-grossing segment in the global ophthalmic ultrasound devices market in 2023 owing to the accessibility and affordability, coupled with the high demand for portable devices, have led major players to provide exchange offers for standalone devices. Additionally, portable/handheld devices is predicted to grow at the fastest CAGR during the forecast period owing to the limited space in ophthalmologist clinics, the increasing healthcare standards, and the continuous introduction of portable ocular ultrasounds featuring advanced capabilities. For instance, in January 2023, Esaote, a prominent Italian company specializing in the biomedical field, particularly in ultrasound, dedicated MRI, and medical IT, unveils the global debut of the MyLab X90, its latest high-end ultrasound system.
By end-user, hospitals was the highest revenue-grossing segment in the global ophthalmic ultrasound devices market in 2023 owing to the supportive government policies promoting the advancement of eye care facilities, a substantial patient population, and the accessibility of advanced technology. Additionally, ophthalmic clinics is predicted to grow at the fastest CAGR during the forecast period owing to the increasing count of ophthalmologists, a rise in the establishment of ophthalmic clinics, a surge in supportive government initiatives, and a growing trend of mergers and acquisitions among market players. For instance, in September 2022, Alcon has completed the acquisition of Ivantis, the creator of the innovative Hydrus Microstent-a minimally invasive glaucoma surgery (MIGS) device intended to reduce eye pressure for individuals with open-angle glaucoma undergoing cataract surgery. This acquisition ensures the seamless integration of Ivantis associates, maintaining business continuity and existing customer relationships.
North America region is anticipated for the highest revenue share during the forecast period owing to a substantial need for advanced medical devices, a rise in diabetes cases, an expanding elderly population, an increased occurrence of eye ailments, and a surge in the introduction of sophisticated devices. For instance, in November 2023, MinXray, a developer of portable digital x-ray technology, has recently introduced a new series of wireless handheld ultrasound devices, specifically the EU-1C ophthalmic scanner. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the elevated unmet needs coupled with the development of healthcare infrastructure, an increasing incidence of ophthalmic disorders, heightened awareness regarding cataract surgeries, and a rise in the introduction of technologically advanced ultrasound devices. For instance, in February 2023, NIDEK CO., LTD., is delighted to introduce the Cube α Ophthalmic Surgical System, featuring innovative ultrasound technology that enhances the potency and efficacy of phacoemulsification.
The Ophthalmic Ultrasound Device plays a vital role in swiftly and non-invasively assessing the eye and orbit. This device becomes essential when manual examination of the eye is challenging. A-scan and B-scan are the two most frequently employed types of Ophthalmic ultrasound devices, used in conjunction to identify eye abnormalities. Ultrasound devices find application in detecting conditions such as choroidal melanoma, retinal detachment, and visualizing lens dislocation. An increase in regulatory approvals for innovative ophthalmic ultrasound devices is predicted to boost the market growth during the forecast period. For instance, in January 2023, The Sunkingdom Ophthalmic Ultrasound Examination Instrument, comprising models SK-3000A, SK-3000B, SK-3000C, SK-2000AP, SK-2000A, and SK-2000P, has received approval from the FDA. Developed by Chongqing Sunkingdom Medical Instrument Co., Ltd., this ultrasound imaging system is designed for ophthalmic applications.
By product, A-scan product was the highest revenue-grossing segment in the global ophthalmic ultrasound devices market in 2023 owing to the extensive utilization of A-scan devices for the pre-operative assessment of conditions like vitreous hemorrhage, peri-orbital trauma, or lens opacification in cases involving a detached retina, offering advantages in cataract surgeries. A-scan employs state-of-the-art transducer and electronic technologies to ensure remarkable reliability and precision in ophthalmology procedures. Additionally, B-scan is predicted to grow at the fastest CAGR during the forecast period owing to the expanding accessibility of these compact, cost-effective, lightweight, and versatile devices, an escalating incidence of diverse diseases, a rising prevalence of diabetic retinopathy, a surge in initiatives by market participants, and an increasing introduction of cutting-edge systems. For instance, in January 2024, FUJIFILM Sonosite Inc. has unveiled the Sonosite LX system in multiple European countries. This latest ultrasound system showcases the company's most extensive clinical image and includes a monitor that can extend, rotate, and tilt, facilitating improved real-time collaboration among healthcare providers.
By modality, standalone devices was the highest revenue-grossing segment in the global ophthalmic ultrasound devices market in 2023 owing to the accessibility and affordability, coupled with the high demand for portable devices, have led major players to provide exchange offers for standalone devices. Additionally, portable/handheld devices is predicted to grow at the fastest CAGR during the forecast period owing to the limited space in ophthalmologist clinics, the increasing healthcare standards, and the continuous introduction of portable ocular ultrasounds featuring advanced capabilities. For instance, in January 2023, Esaote, a prominent Italian company specializing in the biomedical field, particularly in ultrasound, dedicated MRI, and medical IT, unveils the global debut of the MyLab X90, its latest high-end ultrasound system.
By end-user, hospitals was the highest revenue-grossing segment in the global ophthalmic ultrasound devices market in 2023 owing to the supportive government policies promoting the advancement of eye care facilities, a substantial patient population, and the accessibility of advanced technology. Additionally, ophthalmic clinics is predicted to grow at the fastest CAGR during the forecast period owing to the increasing count of ophthalmologists, a rise in the establishment of ophthalmic clinics, a surge in supportive government initiatives, and a growing trend of mergers and acquisitions among market players. For instance, in September 2022, Alcon has completed the acquisition of Ivantis, the creator of the innovative Hydrus Microstent-a minimally invasive glaucoma surgery (MIGS) device intended to reduce eye pressure for individuals with open-angle glaucoma undergoing cataract surgery. This acquisition ensures the seamless integration of Ivantis associates, maintaining business continuity and existing customer relationships.
North America region is anticipated for the highest revenue share during the forecast period owing to a substantial need for advanced medical devices, a rise in diabetes cases, an expanding elderly population, an increased occurrence of eye ailments, and a surge in the introduction of sophisticated devices. For instance, in November 2023, MinXray, a developer of portable digital x-ray technology, has recently introduced a new series of wireless handheld ultrasound devices, specifically the EU-1C ophthalmic scanner. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the elevated unmet needs coupled with the development of healthcare infrastructure, an increasing incidence of ophthalmic disorders, heightened awareness regarding cataract surgeries, and a rise in the introduction of technologically advanced ultrasound devices. For instance, in February 2023, NIDEK CO., LTD., is delighted to introduce the Cube α Ophthalmic Surgical System, featuring innovative ultrasound technology that enhances the potency and efficacy of phacoemulsification.
Segmentation: Ophthalmic Ultrasound Devices Market Report 2023 - 2034
Ophthalmic Ultrasound Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Ultrasound Biomicroscope
- Pachymeter
- Combined
- B-Scan
- A-Scan
Ophthalmic Ultrasound Devices Market Analysis & Forecast by Modality 2023 - 2034 (Revenue USD Bn)
- Portable/Handheld
- Standalone
Ophthalmic Ultrasound Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Ambulatory Surgical Centers (ASCs)
- Hospitals
- Ophthalmic Clinics
- Others
Ophthalmic Ultrasound Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Ophthalmic Ultrasound Devices Market: Product Estimates & Trend Analysis
8. Ophthalmic Ultrasound Devices Market: Modality Estimates & Trend Analysis
9. Ophthalmic Ultrasound Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Ophthalmic Ultrasound Devices Market
12. Europe Global Ophthalmic Ultrasound Devices Market
13. Asia Pacific Global Ophthalmic Ultrasound Devices Market
14. Latin America Global Ophthalmic Ultrasound Devices Market
15. MEA Global Ophthalmic Ultrasound Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- DGH Technology
- Escalon Medical Corp.
- Appasamy Associates
- NIDEK CO. Ltd
- Quantel Medical (Lumibird)
- Ametek Inc.
- Halma plc
- Carl Zeiss Meditec AG
- Ellex Medical Lasers Ltd
- Micro Medical Devices Inc.
- Optos plc (Nikon Corporation)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 0.49 Billion |
| Forecasted Market Value ( USD | $ 1.2 Billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
